Fred E Cooperrider

Array ( [id] => 1344981 [patent_doc_number] => 06582910 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'WbpP and method for assay of WbpP' [patent_app_type] => B1 [patent_app_number] => 09/580929 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18296 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582910.pdf [firstpage_image] =>[orig_patent_app_number] => 09580929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1034537 [patent_doc_number] => 06875747 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-05 [patent_title] => 'Antisense to c-myc for treatment of polycystic kidney disease' [patent_app_type] => utility [patent_app_number] => 09/577250 [patent_app_country] => US [patent_app_date] => 2000-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 13 [patent_no_of_words] => 9575 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875747.pdf [firstpage_image] =>[orig_patent_app_number] => 09577250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420215 [patent_doc_number] => 06506735 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences' [patent_app_type] => B1 [patent_app_number] => 09/575506 [patent_app_country] => US [patent_app_date] => 2000-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5623 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506735.pdf [firstpage_image] =>[orig_patent_app_number] => 09575506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1567992 [patent_doc_number] => 06376750 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Plant seedling and embryo promoter' [patent_app_type] => B1 [patent_app_number] => 09/575574 [patent_app_country] => US [patent_app_date] => 2000-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5330 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376750.pdf [firstpage_image] =>[orig_patent_app_number] => 09575574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720831 [patent_doc_number] => 20030054519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'MICROORGANISMS WITH ABILITY TO DEGRADE INDOLE AND ENZYMES THEREFROM' [patent_app_type] => new [patent_app_number] => 09/570779 [patent_app_country] => US [patent_app_date] => 2000-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8180 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054519.pdf [firstpage_image] =>[orig_patent_app_number] => 09570779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674310 [patent_doc_number] => 20030059913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Novel Microorganisms with ability to degrade indole and novel enzymes therefrom' [patent_app_type] => new [patent_app_number] => 09/570777 [patent_app_country] => US [patent_app_date] => 2000-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8183 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059913.pdf [firstpage_image] =>[orig_patent_app_number] => 09570777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446355 [patent_doc_number] => 06368802 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Circular DNA vectors for synthesis of RNA and DNA' [patent_app_type] => B1 [patent_app_number] => 09/569344 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 22682 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368802.pdf [firstpage_image] =>[orig_patent_app_number] => 09569344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1447288 [patent_doc_number] => 06369202 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Genes encoding LSIRF polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/562466 [patent_app_country] => US [patent_app_date] => 2000-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 35 [patent_no_of_words] => 15776 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369202.pdf [firstpage_image] =>[orig_patent_app_number] => 09562466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4385449 [patent_doc_number] => 06277980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Human papilloma virus inhibition by anti-sense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/560579 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8017 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277980.pdf [firstpage_image] =>[orig_patent_app_number] => 560579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517087 [patent_doc_number] => 06500667 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Aspartyl protease 2 (Asp2) antisense oligonucleotides' [patent_app_type] => B1 [patent_app_number] => 09/551853 [patent_app_country] => US [patent_app_date] => 2000-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 51580 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500667.pdf [firstpage_image] =>[orig_patent_app_number] => 09551853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728213 [patent_doc_number] => 07041507 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-09 [patent_title] => 'Transdiffentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells' [patent_app_type] => utility [patent_app_number] => 09/545428 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14153 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041507.pdf [firstpage_image] =>[orig_patent_app_number] => 09545428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645434 [patent_doc_number] => 07119077 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-10 [patent_title] => 'Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor' [patent_app_type] => utility [patent_app_number] => 09/526298 [patent_app_country] => US [patent_app_date] => 2000-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11423 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119077.pdf [firstpage_image] =>[orig_patent_app_number] => 09526298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577505 [patent_doc_number] => 06448006 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents' [patent_app_type] => B1 [patent_app_number] => 09/515705 [patent_app_country] => US [patent_app_date] => 2000-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8559 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448006.pdf [firstpage_image] =>[orig_patent_app_number] => 09515705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475637 [patent_doc_number] => 06388068 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Method for producing foreign polypeptide in plant intercellular fluid' [patent_app_type] => B1 [patent_app_number] => 09/512342 [patent_app_country] => US [patent_app_date] => 2000-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12479 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/388/06388068.pdf [firstpage_image] =>[orig_patent_app_number] => 09512342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234164 [patent_doc_number] => 06143522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Methods of modulating apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/499082 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 20009 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143522.pdf [firstpage_image] =>[orig_patent_app_number] => 499082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440903 [patent_doc_number] => 06335194 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Antisense modulation of survivin expression' [patent_app_type] => B1 [patent_app_number] => 09/496694 [patent_app_country] => US [patent_app_date] => 2000-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30684 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335194.pdf [firstpage_image] =>[orig_patent_app_number] => 09496694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7607525 [patent_doc_number] => 07098190 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-29 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 09/890363 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 10745 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/098/07098190.pdf [firstpage_image] =>[orig_patent_app_number] => 09890363 [rel_patent_id] =>[rel_patent_doc_number] =>)